Uncategorized
VIDEO: Study — Pretreatment with Fovista improves visual results in patients with neovascular
LAS VEGAS — At the American Academy of Ophthalmology annual meeting, Pravin Dugel, MD, discusses pilot study data in which vision improved in patients with neovascular age-related macular degeneration who were treatment resistant to anti-VEGF therapy and were then pretreated with Fovista (pegpleranib, Ophthotech).